But many panel members said J. & J. recipients might also benefit from the option of a Pfizer-BioNTech or Moderna booster, an action that an F.D.A. official said was possible.

Dr Jenny Harries, the head of the UK Health Security Agency, said a few thousand of the cases missed by the Wolverhampton lab were likely still infectious.

The new CDC recommendations encourage Americans to get vaccinated they  haven't already 'to minimize COVID-19 risk' and 'protect those not yet eligible.'

The Food and Drug Administration’s (FDA) expert vaccine panel on Friday, Oct. 15, recommended a booster dose of the Johnson&Johnson-Janssen COVID-19 vaccine. In a unanimous vote, the 19-member panel recommended the...

The Wall Street Journal reports that the FDA may delay its decision of whether to expand authorization of the Moderna Covid vaccine by a few weeks due to myocarditis concerns.